NICHOLAS GALAKATOS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for NICHOLAS GALAKATOS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of NICHOLAS GALAKATOS. NICHOLAS GALAKATOS is a 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and a Director in NanoString Technologies Inc ($NSTG) and a Director in Ophthotech Corp. ($OPHT) and a in Radius Health, Inc. ($RDUS) and a Director in CATABASIS PHARMACEUTICALS INC ($CATB) and a Director in Entasis Therapeutics Holdings Inc. ($ETTX).
Address: C/O MPM ASSET MANAGEMENT 111 HUNTINGTON AVENUE, 31ST FLOOR BOSTON 02199 MA
Companies in which NICHOLAS GALAKATOS is an Insider
CATABASIS PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of NICHOLAS GALAKATOS: Director
Holdings: 2,752,488 shares
Current Value: $3,385,560
Latest Transaction: Aug 05 2016
$CATB Market Capitalization: $22.76M
$CATB Previous Close: $1.23
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Entasis Therapeutics Holdings Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of NICHOLAS GALAKATOS: Director
Holdings: 361,829 shares
Latest Transaction: Jun 21 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IVERIC bio, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of NICHOLAS GALAKATOS: Director
Holdings: 3,945 shares
Current Value: $17,476
Latest Transaction: Jan 13 2016
$OPHT Market Capitalization: $156.71M
$OPHT Previous Close: $4.43
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NanoString Technologies Inc
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of NICHOLAS GALAKATOS: Director
Holdings: 4,121,848 shares
Current Value: $78,356,330
Latest Transaction: Mar 27 2019
$NSTG Market Capitalization: $400.76M
$NSTG Previous Close: $19.01
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Radius Health, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of NICHOLAS GALAKATOS:
Holdings: 2,459,804 shares
Current Value: $102,967,395
Latest Transaction: Sep 29 2016
$RDUS Market Capitalization: $1.86B
$RDUS Previous Close: $41.86
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RIGEL PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of NICHOLAS GALAKATOS: 10% Owner
Holdings: 1,833,597 shares
Current Value: $4,492,313
Latest Transaction: Jul 07 2004
$RIGL Market Capitalization: $237.45M
$RIGL Previous Close: $2.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of NICHOLAS GALAKATOS
Sentiment: All, CATB, ETTX, OPHT, NSTG, RDUS, RIGL
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 21 2019 | ETTX | Entasis Therapeuti ... | GALAKATOS NICHOLAS | Director | Option Exercise | A | 6.12 | 7,500 | 45,900 | 7,500 | |
| Mar 27 2019 | NSTG | NanoString Technol ... | GALAKATOS NICHOLAS | Director | Option Exercise | A | 23.34 | 4,410 | 102,929 | 4,410 | |
| Jan 22 2019 | ETTX | Entasis Therapeuti ... | GALAKATOS NICHOLAS | Director | Option Exercise | A | 5.66 | 15,000 | 84,900 | 15,000 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | GALAKATOS NICHOLAS | Director | Option Exercise | C | 0.00 | 8,552,024 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | GALAKATOS NICHOLAS | Director | Option Exercise | C | 0.00 | 6,702,213 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | GALAKATOS NICHOLAS | Director | Option Exercise | C | 0.00 | 7,500,000 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | GALAKATOS NICHOLAS | Director | Buy | P | 15.00 | 453,395 | 6,800,925 | 1,623,405 | 1.2 M to 1.6 M (+38.75 %) |